News

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China
ARC Group Celebrates New Chapter with Opening of Hong Kong Office
Capital Markets High Tea 2025: Navigating U.S. Listings and De-SPAC Strategies in Vietnam
Meey Group Selects ARC Group as Exclusive Financial Advisor for Planned U.S. IPO
ARC Group Earns Accreditation as a Great Place To Work-Certified™ Company!
XRP Healthcare Enters LOI for Qualifying Transaction with AAJ Capital 3 Corp., ARC Group Appointed as Exclusive Advisor
ARC Group Advises Cyclacel Pharmaceuticals on Proposed Share Exchange with fitters Sdn. Bhd.
D. Boral Capital and ARC Group Launch Series of SPACs
Sayward Capital Corp. and Technosteel Construction (L.L.C.) Enter Definitive Agreement for Business Combination
Capital Markets and M&A Forum 2025: 10th Anniversary Edition – Celebrating a Decade of Growth, Strategy, and Cross-Border Collaboration
ARC Group Advises BeLive Holdings on Successful Nasdaq IPO
ARC Group Supports Cyclacel Pharmaceuticals in $1 Million Private Placement of Convertible Preferred Stock
UPDATE: SEC Approves Listing Rule Changes
ARC Group's Team-Building Getaway: Strengthening Connections and Celebrating Success
ARC Group Advises on Share Purchase and Change of Control of Cyclacel Pharmaceuticals
ARC Group Successfully Concludes Capital Markets & M&A Forum Shanghai 2025, Celebrating a Decade of Excellence
ARC Group Celebrates a Decade of Excellence
ARC Group Advises Cyclacel Pharmaceuticals on $25M PIPE Financing
D. Boral Capital Secures Strategic Investments from ARC Group and an Institutional Investor
METAVISIO - THOMSON Computing Signs Engagement Agreement with ARC Group for U.S. Listing on Nasdaq or NYSE
Update: NASDAQ Proposed Listing Rule Change
ARC Group Proudly Sponsors Team ARC in the 16th China Cup International Regatta 2024
ARC Group Announces Successful IPO of Gelteq Limited on Nasdaq
ARC Group Successfully Advises Fresenius Medical Care on Strategic Divestment of Six Hospital Centers in China
Green Economy Forum & Exhibition (GEFE) 2024: “A Vital Platform for Europe-Vietnam Cooperation”
ARC Group Receives 2024 Frost & Sullivan Company of the Year Award for Excellence in Asian Mid-Market Investment Advisory
ARC Group Featured in The Smart Investor’s Exclusive September-October 2024 Edition
ARC Group Announces Successful Nasdaq Listing of CURRENC Group Inc.
Navigating Global Growth: ARC Group's Beijing Forum on Strategic Expansion in Capital Markets and M&A